News Detail
Mumbai, 17 Feb 2025: According to the EY report, 60% of survey participants from the healthcare and Life Sciences sector believe Gen AI will have a significant impact on the entire value chain. The report, titled, 'View Details
Source : EY India
Artificial Intelligence in Healthcare
AI-driven Solutions in India
Indian Pharma Companies
AI in Drug Discovery
Generative AI in Pharmaceuticals
Productivity Gains through AI
Healthcare AI Projects
EY Report on AI Investment
Manufacturing AI Solutions
Related News
- DCA Telangana cracks down on overpricing and misleading drug claims (22-02-2025)
- DCA busts unlicensed manufacturing drugs unit in Sangareddy (22-02-2025)
- A committee formed in Dehradun, to address the issue of companies producing counterfeit medications (22-02-2025)
- Govt Intensifies Inspections at Pharmaceutical Facilities to Ensure Quality (22-02-2025)
- BioAsia 2025 to host Global Healthcare Leaders to drive transformative innovation (22-02-2025)
- Bihar Takes Firm Stance Against Counterfeit Medicines, Health Secretary Issues Strong Directives (22-02-2025)
- Bombay HC Quashes Income Tax Reassessment Notice Against Lupin Ltd For AY 2016-17 (22-02-2025)
- Govt extends Rajeev Singh Raghuvanshi's tenure as DCGI by one year (22-02-2025)
- CrisprBits develops PathCrisp for detection of AMR (22-02-2025)
- Medicines valued at Rs 2 lakh confiscated from Hans Foundation Chhabra office (21-02-2025)